Odyssey

Content Creation, Collaboration, and Community Building in 3D

General Information
Company Name
Odyssey
Founded Year
2016
Location (Offices)
The Netherlands +1
Founders / Decision Makers
Number of Employees
11
Industries
Blockchain, IT, Web3
Funding Stage
Seed
Social Media

Odyssey - Company Profile

Odyssey is a Netherlands-based blockchain startup that focuses on Content Creation, Collaboration, and Community Building in 3D. Established in 2016, Odyssey recently secured a €4.00M Seed Round investment on 04 November 2021 from notable investors including Maven 11, BR Capital, Scytale Ventures, Ewald Hesse, Trent McConaghy, and Ben Woldring. The company's slogan underscores its commitment to utilizing 3D technology for content creation and community engagement. With the recent launch of Odyssey Beta on testnet, the startup is poised to take significant strides in revolutionizing the blockchain industry. Interested parties can apply for early access to Odyssey at https://odyssey.org/. The unique intersection of blockchain technology and 3D content creation positions Odyssey as a promising player in the evolving landscape of digital innovation.

Taxonomy: 3D technology, Content creation, Collaboration platform, Community building, Virtual reality, Testnet, Early access, Blockchain technology

Funding Rounds & Investors of Odyssey (1)

View All
Funding Stage Amount No. Investors Investors Date
Seed Round €4.00M 6 Ewald Hesse, Trent McConaghy +1 04 Nov 2021

Latest News of Odyssey

View All

No recent news or press coverage available for Odyssey.

Similar Companies to Odyssey

View All
Gen 777 - Silver Odyssey - Similar company to Odyssey
Gen 777 - Silver Odyssey Futuristic events brand
Odyssey Thera - Similar company to Odyssey
Odyssey Thera Pioneering cellular pharmacology to discover groundbreaking cancer therapies.
Odyssey - Similar company to Odyssey
Odyssey Put your experiences into action. Create content, join meaningful conversations, and learn new perspectives today.
Rahko - Similar company to Odyssey
Rahko Part of Odyssey Therapeutics